Cipta Sarana Medika Tbk. vs Griptha Putra Persada Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Griptha Putra Persada Tbk. trades at Rp59 (market cap 60B, 661.3K 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 2.6× Griptha Putra Persada Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 661.3K). Which is the better fit depends on your goals.
| DKHH | GRPH | |
|---|---|---|
Market Cap | 158.12B | 60B |
Volume | 8.21M | 661.3K |
Lot | 82.15K | 6.61K |
Turnover | 515.2M | 39.67M |
Average Price | 62.72 | 59.99 |
Value | 515.2M | 39.67M |
Indicative Equilibrium Price | 63 | 59 |
Indicative Equilibrium Volume | 1.33K | 640 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Griptha Putra Persada Tbk (the Company), was established based on Notarial Deed No. 26 dated April 14, 2010 of Drs. Ika Slamet Riyono, S.H., notary in Kudus. The Company started its commercial operation in July 1, 2015. The Company’s immediate parent company is PT Mulia Jaya Palma and the ultimate controlling shareholder of the Company is Samuel Jeffrey Christiawan Soegeng.
Read more on GRPH →